Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs

International Journal of Impotence Research

Volumn 15, Issue 2, 2003, Pages 137-141

  Angulo, J ^a   Cuevas, P ^a   Cuevas, B ^a   Bischoff, E ^b   Saenz de Tejada I ^a,c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b BAYER AG   (Germany)

^c Fund Invest Desarrollo/Andrologia   (Spain)

Author keywords

PDE5 inhibitor; Sexual dysfunction

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; VARDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CLITORAL BLOOD FLOW; CLITORIS; CONTROLLED STUDY; DOG; DRUG MECHANISM; ELECTROSTIMULATION; FEMALE; FEMALE SEXUAL DYSFUNCTION; GENITAL SYSTEM; NERVE STIMULATION; NONHUMAN; PELVIC NERVE ELECTRICAL STIMULATION; PENILE SMOOTH MUSCLE; PENIS ERECTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SMOOTH MUSCLE; VAGINA BLOOD FLOW; VASODILATATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CLITORIS; DOGS; ELECTRIC STIMULATION; FEMALE; HYPOGASTRIC PLEXUS; IMIDAZOLES; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; REGIONAL BLOOD FLOW; SULFONES; TRIAZINES; VAGINA;

EID: 0038577118     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900985     Document Type: Article

References (27)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-544.
2. Park K et al. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997; 9: 27-37.
3. Vachon P, Simmerman N, Zahran AR, Carrier S. Increases in clitoral and vaginal blood flow following clitoral and pelvic plexus nerve stimulations in the female rat. Int J Impot Res 2000; 12: 453-57.
4. Giuliano F et al. Vaginal physiological changes in a model of sexual arousal in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 2001; 281: R140-R149.
5. Cellek S, Moncada S. Nitrergic neurotransmission mediates the non-adrenergic responses in the clitoral corpus cavernosum of the rabbit. Br J Pharmacol 1998; 125: 1627-1629.
6. Vemulapalli S, Kurowski S. Sildenafil relaxes rabbit clitoral corpus cavernosum. Life Sci 2000; 67: 23-29.
7. Ziessen T, Moncada S, Cellek S. Characterization of the nonnitrergic NANC relaxation responses in the rabbit vaginal wall. Br J Pharmacol 2002; 135: 546-554.
8. Sáenz De Teiada I et al. The phosphodiesterase inhibitory selectivity and the in vivo and in vitro potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 2001; 13: 282-290.
9. Porst H et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001; 13: 192-199.
10. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction. Classification, evaluation and treatment options. Eur Urol 2000; 38: 20-29.
11. Laan E, Everaerd W, Evers A. Assessment of female sexual arousal: response specificity and construct validity. Psychophysiology 1995; 32: 476-485.
12. Berman JR et al. Clinical evaluation of female sexual function: effects of age and estrogen status on subjective and physiologic sexual responses. Int J Impot Res 1999; 11 (Suppl 1): S31-S38.
13. Wagner G, Levin RJ. Oxygen tension of the vaginal surface during sexual stimulation in the human. Fertil Steril 1978; 30: 50-53.
14. Giraldi A et al. Effects of diabetes on neurotransmission in rat vaginal smooth muscle. Int J Impot Res 2001; 13: 58-66.
15. Ottesen B et al. Vasoactive intestinal polypeptide provokes vaginal lubrication in normal women. Peptides 1987; 8: 797-800.
16. Levin RJ. VIP, vagina, clitoral and periurethral glans: an update on female genital arousal. Exp Clin Endocrinol 1991; 98: 61-69.
17. Hoyle CH et al. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptidecontaining nerves. J Anat 1996; 188: 633-664.
18. Burnett AL et al. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 1997; 158: 75-78.
19. Park K et al. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1998; 249: 612-617.
20. Min K et al. Sildenafil augments pelvic nerve-mediated female genital arousal in the anesthetized rabbit. Int J Impot Res 2000; 12 (Suppl 3): S32-S39.
21. Ralfer J et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-94.
22. Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404.
23. Padma-Nathan H et al. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001; 13: 2-9.
24. Kaplan SA et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999; 53: 481-486.
25. Nurnberg HG et al. Sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatr Serv 1999; 50: 1076-1078.
26. Sipski ML, Rosen RC, Alexander CJ, Hamer RM. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 2000; 55: 812-815.
27. Berman JR et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001; 27: 411-420.